The Middle East & Africa kidney disease market is expected to reach US$ 7,406.2 million in 2027 from US$ 4,834.1 million in 2019. The market is estimated to grow with a CAGR of 5.5% from 2020-2027.
Kidney disease means that the kidneys are damaged and cannot filter blood as they should. This damage can cause wastes to build up in your body. Diabetes and high blood pressure are the most common causes of kidney disease. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others.The scope of the kidney disease market includes product, end-user, and region.
Saudi Arabia Kidney Disease Market Revenue and Forecasts to 2027 (US$ MN)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Market Insights
Increased Prevalence of Obesity across the Region
Every country in the Middle East & Africa region is currently facing an increasing prevalence of obesity due to multiple factors. A sedentary lifestyle and unhealthy eating habits contribute majorly to obesity in an individual. Along with a lack of physical activity and mounting stress are contributing as well. According to a report ‘2018ReviewEnd-stage Renal Disease in the Middle East: A Systematic Review and Meta-analysis’, it is estimated that the annual cost for CKD and ESRD is $48 billion and $32.9 billion and is rising due to cases of obesity.As perthe report ‘Chronic Kidney Disease in Arab World: A Call for Action,’obesity is also related to CKD epidemiology since obesity appears to be an essential risk factor for CKD. The prevalence of obesity has increased over the past two decades. Over 3,000 million adults worldwide are obese. The majority of a body mass index of at least 35 among incident dialysis patients has increased by 64% over the past decade. If trends continue, 20% of all patients will initiate dialysis with this degree of obesity. In Syria, obesity was 38.2%, with the prevalence in women nearly one and half times more than in men. Obesity affects 16–50% of individuals with diabetes in the Arab world, 20–38% have hyperlipidemia, 24–46% have hypertension and, although data are incomplete, nephropathy and retinopathy rates appear to be relatively high. Moreover, in a review of obesity prevalence in the Arab world, it was concluded that one-third of Arabs are obese, and women have notably higher rates of obesity as defined by a body mass index of 30.Thus, an increase in the prevalence of obesity in the Middle East & Africa region is likely to create lucrative opportunities for market growth.
Product- Based Market Insights
Based on product,thekidney disease marketis segmented into diagnosis and treatment. The diagnosis segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.
End-User - Based Market Insights
Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories, and others. The hospitals segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.
Middle East & Africa Kidney Disease Market, by End-User – 2019 and 2027

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Middle East and Africa Kidney Disease Market: Strategic Insights
Middle East and Africa Kidney Disease Market
-
Market Size 2019
US$ 4,834.1 Million
-
Market Size 2027
US$ 7,406.2 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Regional Overview
- Middle East and Africa
Market Segmentation
Product
- Diagnosis and Treatment
End User
- Hospitals
- Diagnostic Laboratories
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Middle East and Africa Kidney Disease MarketReport ScopeMiddle East and Africa Kidney Disease Market Report Scope
Report Attribute
Details
Market size in 2019
US$ 4,834.1 Million
Market Size by 2027
US$ 7,406.2 Million
Global CAGR (2020 - 2027)
5.5%
Historical Data
2017-2018
Forecast period
2020-2027
Segments Covered
By Product - Diagnosis and Treatment
By End User - Hospitals
- Diagnostic Laboratories
Regions and Countries Covered
Middle East and Africa - South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
Market leaders and key company profiles
Abbott
F. Hoffmann-La Roche Ltd
AbbVieInc
Pfizer Inc
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline plc
Sysmex Corporation
Siemens AG
Amgen Inc
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Middle East and Africa Kidney Disease Market: Strategic Insights
-
Market Size 2019
US$ 4,834.1 Million -
Market Size 2027
US$ 7,406.2 Million

Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Regional Overview

- Middle East and Africa
Market Segmentation

- Diagnosis and Treatment

- Hospitals
- Diagnostic Laboratories
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 4,834.1 Million |
Market Size by 2027 | US$ 7,406.2 Million |
Global CAGR (2020 - 2027) | 5.5% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | Middle East and Africa
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset


- Bioremediation Technology and Services Market
- Explosion-Proof Equipment Market
- Dropshipping Market
- Sleep Apnea Diagnostics Market
- Animal Genetics Market
- Space Situational Awareness (SSA) Market
- Personality Assessment Solution Market
- Fishing Equipment Market
- Joint Pain Injection Market
- Malaria Treatment Market

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Product, End User, and Country

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Saudi Arabia
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Middle East and Africa Kidney Disease Market
- Abbott
- F. Hoffmann-La Roche Ltd
- AbbVieInc
- Pfizer Inc
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc
- Sysmex Corporation
- Siemens AG
- Amgen Inc